跳至主要内容
临床试验/CTRI/2020/07/026757
CTRI/2020/07/026757尚未招募3 期

A prospective double blind randomised controlled trial of Eupatorium perfoliatum 30 C in asymptomatic and mild symptomatic cases of COVID-19.

Ministry of AYUSH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects testing positive for SARS CoV-2 by RT-PCR, presenting with no symptoms or mild symptoms.
  • 2. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

排除标准

  • 1. Cases of COVID-19 with clinical severity ranging from moderate to critical.
  • 2. Pregnant and lactating females.
  • 3. Subjects having uncontrolled and unstable co morbidity.
  • 4. Immunocompromised subjects or those taking any kind of immunosupressive therapy.
  • 5. COVIC-19 positive cases participating as subjects in other COVID-19 clinical trails.
  • 6. Subjects having past history of allergy to any medicine that is part of the Homoeopathic intervention. Other conditions, which in the opinion of the investigator, makes the patient unsuitable for enrollment or could interfere with his participation in, and completion of the protocol.

研究者

相似试验